Mather Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$935K Buy
1,664
+190
+13% +$122K 0.01% 346
2025
Q4
$997K Buy
1,474
+25
+2% +$17K 0.01% 282
2025
Q3
$926K Sell
1,449
-13
-0.9% -$7.89K 0.01% 292
2025
Q2
$784K Buy
1,462
+702
+92% +$336K 0.01% 311
2025
Q1
$319K Buy
760
+329
+76% +$143K ﹤0.01% 475
2024
Q4
$178K Sell
431
-186
-30% -$81.6K ﹤0.01% 603
2024
Q3
$312K Buy
617
+23
+4% +$11.2K ﹤0.01% 456
2024
Q2
$321K Buy
594
+24
+4% +$12K ﹤0.01% 516
2024
Q1
$316K Sell
570
-8
-1% -$4.37K 0.01% 430
2023
Q4
$321K Sell
578
-102
-15% -$47.9K 0.01% 440
2023
Q3
$297K Buy
680
+208
+44% +$104K 0.01% 442
2023
Q2
$237K Buy
+472
New +$226K ﹤0.01% 512
2022
Q2
Sell
-389
Closed -$213K 429
2022
Q1
$213K Buy
+389
New +$205K ﹤0.01% 418

Other funds holding IDXX

Mather Group's IDXX Position: Q1 2026 in Review

Mather Group increased its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, buying an estimated $122K and bringing the position to 1,664 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #346.

Mather Group first reported a position in IDXX in Q1 2022 and has held it in 13 quarters since. The position peaked at $997K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Mather Group held 1,664 shares of Idexx Laboratories worth $935K as of Q1 2026.
  • Mather Group bought 190 Idexx Laboratories shares in Q1 2026, an estimated $122K.
  • Idexx Laboratories made up 0.01% of Mather Group's portfolio in Q1 2026, its #346 holding.
  • Mather Group first reported a position in Idexx Laboratories in Q1 2022 and has held it in 13 quarters since.
  • Mather Group's Idexx Laboratories position peaked at $997K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.